Ligand validation:8GT0

PE8: 3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL

PE8 is a Ligand Of Interest in 8GT0 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GT0_PE8_A_322	51%	80%	0.152	0.904	0.53	0.32	-	-	7	0	100%	1
8GT0_PE8_B_121	44%	82%	0.186	0.915	0.53	0.27	-	-	0	0	100%	1
8GT0_PE8_C_322	41%	83%	0.175	0.888	0.53	0.26	-	-	0	0	100%	1
8GT0_PE8_A_323	36%	81%	0.188	0.88	0.54	0.29	-	-	0	0	100%	1
8GT0_PE8_E_113	30%	83%	0.203	0.864	0.53	0.26	-	-	6	0	100%	1
8GT0_PE8_B_105	26%	79%	0.231	0.875	0.53	0.35	-	-	5	0	100%	1
8GT0_PE8_E_114	24%	80%	0.202	0.832	0.53	0.32	-	-	4	0	100%	1
8GT0_PE8_B_122	24%	82%	0.216	0.846	0.53	0.28	-	-	0	0	100%	1
8GT0_PE8_A_324	22%	77%	0.218	0.837	0.54	0.38	-	-	2	0	100%	1
8GT0_PE8_E_112	18%	81%	0.214	0.797	0.53	0.3	-	-	0	0	100%	1
8GT0_PE8_B_131	14%	84%	0.332	0.889	0.53	0.25	-	-	3	0	100%	1
8GT0_PE8_B_123	12%	80%	0.259	0.791	0.53	0.31	-	-	2	0	100%	1
8GT0_PE8_C_321	11%	78%	0.271	0.783	0.54	0.37	-	-	5	0	100%	1
8GT7_PE8_E_109	69%	85%	0.121	0.934	0.48	0.27	-	-	4	0	100%	1
3L9V_PE8_A_1	98%	37%	0.063	0.982	0.59	1.85	-	7	3	0	100%	1
7EKV_PE8_A_202	73%	79%	0.118	0.945	0.51	0.36	-	-	2	0	100%	1
4EY4_PE8_B_608	71%	41%	0.09	0.909	0.64	1.64	-	1	1	0	100%	1
5J2Z_PE8_A_513	70%	72%	0.122	0.94	0.55	0.55	-	-	4	0	100%	1
4D1G_PE8_G_1346	69%	73%	0.119	0.932	0.5	0.54	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.